US Bancorp
TYRA icon

US Bancorp’s Tyra Biosciences TYRA Stock Holding History

US Bancorp’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11
Closed -$421 – 4344
2026
Q1 		$421 Buy
+11
New +$356 ﹤0.01% 4019
2025
Q3 		– Sell
-7,561
Closed -$72.4K – 4290
2025
Q2 		$72.4K Buy
7,561
+2,126
+39% +$20.2K ﹤0.01% 2603
2025
Q1 		$50.5K Buy
5,435
+1,823
+50% +$23.6K ﹤0.01% 2740
2024
Q4 		$50.2K Buy
+3,612
New +$65.5K ﹤0.01% 2737

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

US Bancorp's TYRA Position: Q2 2026 in Review

US Bancorp sold out of Tyra Biosciences (TYRA) in Q2 2026, closing a stake of 11 shares — an estimated $421 sold.

US Bancorp first reported a position in TYRA in Q4 2024 and held it in 4 quarters. The position peaked at $72.4K in Q2 2025. 168 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • US Bancorp reported no remaining Tyra Biosciences position as of Q2 2026 after selling out during the quarter.
  • US Bancorp sold 11 Tyra Biosciences shares in Q2 2026, an estimated $421.
  • US Bancorp first reported a position in Tyra Biosciences in Q4 2024 and held it in 4 quarters.
  • US Bancorp's Tyra Biosciences position peaked at $72.4K in Q2 2025.
  • 168 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.